Prime Securities’ Jayakumar Says Pharma A Safe Bet Amid VolatilityÂ
The Indian equity markets have erased 2018 gains as capital outflows continue on expectation of rising rates in the U.S., aggravating the selloff caused by surging crude, a weaker rupee and liquidity fears in the money market.
For N Jayakumar, managing director of Prime Securities, this is the best time for bottom fishing, especially in the pharmaceutical sector. With 60 percent of the market floating at 50 percent or lower than its all-time highs, he said pharma stocks have been able to withstand volatility.
Many of the pharma stocks have corrected over the last several quarters while addressing regulatory challenges, Jayakumar said in an interview with BloombergQuint. “It will be the No. 1 space since the stocks have not adjusted to the dollar-rupee potential at a 74-plus level.”
Nifty 50 Index is trading nearly flat compared with the start of 2018, erasing gains as the current account deficit widened because of rising oil prices and a weaker rupee. Foreign investors have pulled out nearly Rs 80,000 crore from both debt and equity markets as the U.S. Federal Reserve has reiterated its resolve to keep increasing rates. The Indian benchmarks fell sharply since mid-September when defaults by Infrastructure Leasing and Financial Services Ltd. triggered a liquidity crunch for non-bank lenders.
Jayakumar said all hope is not lost for non-banking financial companies which are trading at 1-1.5 times their book value, he said. “As credit picks up, they could give you upsides from valuations.” Still, at the current levels of the equity indices, he expects that pharmaceuticals and public sector banks could “give surprise upside returns”.
Other Key highlights from the conversation:
Market Volatility
- The biggest global factor affecting the Indian markets has been rising interest rates in the U.S. and declining liquidity.
- The two factors affecting the market are foreign flows or outflows, as the case may be, and oil prices.
- Micros are looking far better and macros.
Crude
- Commodity prices are weakening and crude is no exception.
- Nothing affects the Indian market more than oil prices.
- Nothing moves Indian markets on a index basis more than a weak crude.
- Brent crude prices will most likely revert to $75 a barrel by the last quarter of this year.
Portfolio Purchases in NBFCs:
- NBFCs need to be given a liquidity lifeline.
- Regulatory changes need to happen in a staggered manner or the consequences of a liquidity squeeze could be disastrous.
- All is not lost for the NBFC space and there will be an anchor for growth.
- Most of the companies are trading at 1-1.5 times the book value.
- As credit picks up, they could give you upsides from these valuations.
- Pharmaceuticals and state-owned banks could give surprise returns.
Top Themes With A Three-Year View
- Businesses related to airports seeing a visible, consumer-related growth.
- The airport sector is here to grow.
- Ancillary services, along with airports and aviation stocks, is a great investment from a two- to three-year perspective.
- Public sector banks are a great investment.
- The frontline stocks are quoting below the book and could give decent upside returns from here.
Watch the full interview here:
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.